相关实验视频

Updated: Jan 8, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

跨导管大动脉植入与手术大动脉置换的全国中期结果

Suk Ho Sohn¹, Kyung Hwan Kim¹, Yoonjin Kang¹

¹Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Annals of thoracic surgery short reports

|December 22, 2025

概括

跨导管大动脉植入 (TAVI) 和外科大动脉置换 (SAVR) 在韩国大人口中显示了类似的中期存活率. 这些发现适用于所有年龄组,为大动脉置换策略提供了宝贵的见解.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
心脏外科手术心脏外科手术

背景情况:

大动脉狭窄是一种常见的膜性心脏病.
过导管大动脉植入 (TAVI) 和外科大动脉置换 (SAVR) 是主要的治疗选择.
现实世界的比较结果数据对于临床决策至关重要.

研究的目的:

为了比较TAVI与SAVR的早期和中期结果.
为了评估现实世界的韩国人口的结果.
评估不同年龄小组的结果.

主要方法:

韩国1468名TAVI和3897名SAVR患者的回顾性分析 (2015年6月至2019年5月).
倾向性得分匹配分析,以平衡基线特征.
根据年龄 (<65,65-69,70-74,75-79,80-84,≥85岁) 进行子组分析.

主要成果:

在整体队列中,围手术死亡率没有显著差异;SAVR在匹配队列中死亡率更高.
在匹配的队列和所有年龄小组中,TAVI和SAVR之间的所有原因死亡率的可比累积发病率.
对于中风,内心炎和重新干预的中期结果类似;TAVI的永久心脏起器植入率更高.

结论:

TAVI和SAVR在现实世界的韩国人口中显示了可比的中期生存率.
在所有年龄分组中,TAVI和SAVR的中期存活率都相似.
这些发现支持基于患者特异性因素和年龄的TAVI和SAVR的使用.

更多相关视频

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

相关概念视频

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...